The occurrence of IAI is predominately triggered during surgery, when bacteria from the surgical site transfer to the implant surface and initiate a sequence of attachment, proliferation, and maturation. [2] This sequence leads to the establishment of a biofilm, which is characterized by an aggregation of bacterial cells attached to the implant surface and embedded in a matrix of extracellular polymeric substance (EPS). [3] The biofilm lifestyle affords bacteria an improved ability to avoid clearance by the host immune system and antibacterial drugs. [4] It is well established that bacterial biofilms enhance antibiotic resistance by up to 1000-fold, [5] and in most cases, antibiotics alone are insufficient to eliminate IAI. [6] Further, complications arise when multiple pathogenic species co-aggregate, as biofilm formation can be enhanced depending on the species composition. [7] This is concerning because polymicrobial infections account for a considerable proportion of IAI. For example, ≈15-19% of orthopedic implant infections involve more than one pathogenic species. [2,8] Staphylococcus aureus is the most common pathogen identified in IAI, [9] among other culprits such as Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, and Candida albicans, among others. [8b] Mixed species biofilms can also promote the emergence of drug resistant bacteria, as biofilm-associated cells share genetic elements through horizontal gene transfer. [10] Beyond this, crossspecies interactions can benefit one or more species within the composition by mitigating unfavorable environmental conditions. [11] An example of this is seen during infection, when the host limits iron availability as a defense mechanism. [12] When E. faecalis is co-localized with E. coli, these iron limiting conditions trigger E. faecalis to induce the upregulation of siderophore biosynthesis by E. coli, enhancing its iron uptake, and supporting it to overcome the host defense mechanism. [13] This seemingly altruistic behavior of E. faecalis may ultimately cycle back to a realized benefit for itself if the E. coli isolate in the composition is carbapenemase-producing, as E. faecalis benefits from the presence of this drug resistance enzyme. [14] These mutually beneficial interactions lead to a concerning outcome, as co-infections of E. faecalis and E. coli have been shown to be significantly more virulent than their single-species counterparts. [15] An ever-present risk of medical device associated infection has driven a significant body of research toward development of novel anti-infective materials. Surfaces bearing sharp nanostructures are an emerging technology to address this concern. The in vitro efficacy of antimicrobial nanostructures has previously been verified using single species cultures, but there remains a paucity of data to address the threat of infections containing more than one species. Polymicrobial infections are a concerning threat because they can complicate treatment, promote drug resistance, and ...